Biotech and Pharma Industry News | BioPharma Dive
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA …
Pharma News | BioPharma Dive
2024年11月20日 — The latest pharma news for biotech and biopharmaceutical professionals
Biotech News - BioPharma Dive
6 天之前 — The latest biotech news for biopharmaceutical professionals. 23andMe to lay off more than 200 employees amid business struggles The genetic testing firm will also close its drug …
Two decades and $200 billion: AbbVie’s Humira monopoly nears …
2022年3月17日 — All told, AbbVie filed about 250 patent applications for Humira in the U.S., 90% of them following the drug's 2002 approval, according to the advocacy group Initiative for …
Meso Scale Discovery (MSD): An immunoassay platform with …
2022年2月22日 — ADVANTAGES. Sensitivity, Range and Ease-of-Use: In comparison to a conventional ELISA, MSD has higher sensitivity (LLOD 0.1-1.4 pg/mL) and a larger dynamic …
Novartis wins FDA approval for new heart drug, but faces uphill …
2021年12月22日 — Novartis on Wednesday won Food and Drug Administration approval for a genetic drug that can powerfully lower cholesterol with just two injections a year, one that it …
Zepbound, Mounjaro back in supply as Lilly resolves shortage
2024年8月5日 — Dive Insight: Lilly has been pouring money into expanding its manufacturing capacity for tirzepatide by opening production at more of its existing facilities, buying factories …
Biotech IPOs are the industry’s lifeblood. Track how they’re …
2024年10月24日 — Septerna is the 23rd biotech to go public this year, pushing 2024’s IPO activity above the totals reached in both 2023 and 2022.
FDA approves Sanofi’s long-lasting hemophilia drug
2023年2月23日 — Yet, Altuviiio may soon face added competition. BioMarin Pharmaceutical, for example, is attempting to secure approval for a hemophilia A gene therapy that, in some …
Backed by billionaires, a new biomedical institute tests an …
2024年1月12日 — Arena isn’t organized around a particular therapeutic area or drugmaking technology. The group identified brain health, oncology and immunology as areas it plans to …